Although the impact of supplementary treatments, specifically cryotherapy, laser photocoagulation, or anti-VEGF intravitreal therapy, has generally demonstrated favourable outcomes, particularly in infants diagnosed with ROP stage 4B, subsequent analysis should be performed in order to compare the effect of these treatments as either preoperative or concurrent therapeutic options. The gene discussed is VEGFA; the disease is retinopathy of prematurity.